Complete Filing Data
Rafael Holdings, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $96.63 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Rafael Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$30.5M | -$34.4M | -$1.9M | -$124.7M | -$23.1M | -$10.8M | -$4.7M | -$11.6M | $138.0K | $710.0K |
| Revenues | $917.0K | $637.0K | $279.0K | $410.0K | $802.0K | $4.9M | $4.9M | $4.4M | $5.6M | $5.6M |
| Operating Income Loss | -$29.2M | -$102.6M | -$15.0M | -$60.5M | -$28.2M | -$8.5M | -$6.7M | -$3.8M | $221.0K | $1.2M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$33.2M | -$67.3M | -$8.7M | -$140.0M | -$23.4M | -$6.9M | -$4.9M | -$3.6M | $204.0K | $1.2M |
| Comprehensive Income Net Of Tax | -$30.2M | -$34.0M | -$2.2M | -$124.7M | -$24.8M | -$10.8M | -$4.5M | -$10.5M | $2.3M | $703.0K |
| Income Tax Expense Benefit | -$2.6M | -$2.7M | -$255.0K | $18.0K | $29.0K | -$19.0K | $8.4M | $66.0K | $449.0K | |
| Research And Development Expense | $12.8M | $4.2M | $6.3M | $8.7M | $4.9M | $2.4M | $1.0M | $995.0K | ||
| Net Income Loss Attributable To Noncontrolling Interest | -$123.0K | -$30.6M | -$339.0K | -$17.7M | -$222.0K | -$338.0K | -$231.0K | -$427.0K | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$30.3M | -$64.6M | -$2.5M | -$142.4M | -$10.8M | -$4.6M | -$10.3M | $2.3M | $703.0K | |
| Revenue From Related Parties | $111.0K | $108.0K | $2.1M | $2.1M | $2.2M | $3.7M | $3.7M | |||
| Operating Leases Income Statement Lease Revenue | $179.0K | $214.0K | $1.5M | $1.5M | $1.3M | $989.0K | $746.0K | |||
| Selling General And Administrative Expense | $17.0M | $17.0M | $9.1M | $8.8M | $5.5M | $3.7M | $2.8M | |||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$96.0K | $53.0K | $42.0K | $5.0K | -$10.0K | |||||
| Parking Revenues | $502.0K | $832.0K | $874.0K | $873.0K | $924.0K | $1.1M | ||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $96.0K | -$53.0K | $10.0K | -$22.0K | $298.0K | $166.0K | $27.0K | -$7.0K | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $247.0K | $464.0K | -$290.0K | -$63.0K | $1.9M | $2.1M | ||||
| In Process Research And Development | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.7M | ||||
| Interest Income Expense Net | -$102.0K | -$32.0K | $469.0K | $16.0K | $10.0K | -$20.0K | ||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$336.0K | -$17.7M | $24.5M | $10.4M | -$173.0K | $107.0K | ||||
| General And Administrative Expense | $13.8M | $8.9M | $8.9M | $17.0M | ||||||
| Income Loss From Equity Method Investments | -$1.6M | -$575.0K | $383.0K | $192.0K | -$104.0K | |||||
| Deferred Income Taxes And Tax Credits | $6.0K | $13.0K | -$19.0K | $8.9M | -$295.0K | $368.0K | ||||
| Revenues Other Related Party | $120.0K | $480.0K | $480.0K | $480.0K | ||||||
| Cost Of Revenue | $154.0K | |||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$1.45 | -$0.36 | -$6.22 | -$1.38 | ||||||
| Income Loss From Continuing Operations Per Basic Share | -$1.45 | -$0.36 | -$6.22 | -$1.38 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.4M | -$9.8M | -$290.0K | -$4.8M | -$4.6M | -$9.0M | -$32.4M | $6.0M | -$3.6M | -$1.4M | -$3.3M | $1.6M | -$5.5M | -$2.1M | -$128.9M | -$2.7M | -$8.2M | -$1.4M | -$2.2M | -$1.3M | -$1.6M | -$1.0M | -$1.0M | -$481.0K | -$635.0K | -$531.0K | -$546.0K | -$9.3M | -$91.0K | -$65.0K | $166.0K |
| Revenues | $211.0K | $240.0K | $362.0K | $77.0K | $128.0K | $336.0K | $68.0K | $68.0K | $71.0K | $70.0K | $70.0K | $76.0K | $74.0K | $191.0K | $990.0K | $959.0K | $1.1M | $1.2M | $1.2M | $1.2M | $1.4M | $1.0M | $1.1M | $1.2M | $1.1M | $956.0K | $1.1M | $1.6M | $1.3M | $1.3M | |
| Operating Income Loss | -$6.7M | -$10.1M | -$5.9M | -$6.6M | -$3.8M | -$93.2M | -$3.1M | -$2.5M | -$3.0M | -$4.3M | -$5.1M | -$4.7M | -$1.6M | -$49.5M | -$3.5M | -$10.8M | -$2.5M | -$2.0M | -$1.9M | -$1.5M | -$1.4M | -$1.4M | -$1.1M | -$1.2M | -$731.0K | -$816.0K | -$1.1M | $100.0K | -$164.0K | $127.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.3M | -$9.8M | -$6.5M | -$5.3M | -$9.2M | -$64.9M | $6.1M | -$3.5M | -$1.8M | -$3.2M | -$5.2M | -$5.0M | -$2.1M | -$128.3M | -$2.7M | -$8.3M | -$1.5M | -$2.3M | -$1.3M | -$1.6M | -$1.2M | -$684.0K | -$696.0K | -$664.0K | -$707.0K | -$900.0K | -$27.0K | $180.0K | |||
| Comprehensive Income Net Of Tax | -$6.4M | -$9.8M | -$4.7M | -$4.6M | -$9.0M | -$32.3M | $6.2M | -$3.5M | -$2.2M | -$3.0M | $1.7M | -$5.8M | -$2.1M | -$129.4M | -$2.6M | -$8.1M | -$1.5M | -$2.2M | -$1.3M | -$1.6M | -$1.2M | -$636.0K | -$596.0K | -$1.0M | -$673.0K | -$9.3M | -$43.0K | $174.0K | |||
| Income Tax Expense Benefit | $48.0K | $10.0K | -$2.4M | $20.0K | $12.0K | -$2.6M | $6.0K | -$269.0K | $5.0K | $5.0K | $2.0K | $4.0K | $4.0K | $4.0K | $5.0K | $8.0K | $12.0K | $4.0K | -$7.0K | $17.0K | -$31.0K | -$5.0K | $15.0K | $8.4M | $38.0K | $14.0K | |||||
| Research And Development Expense | $4.5M | $7.5M | $232.0K | $3.0M | $947.0K | $1.3M | $1.5M | $612.0K | $489.0K | $740.0K | $2.2M | $2.1M | $1.4M | $3.3M | $2.2M | $1.3M | $1.6M | $515.0K | $634.0K | $448.0K | $245.0K | $300.0K | $276.0K | $373.0K | |||||||
| Net Income Loss Attributable To Noncontrolling Interest | $90.0K | $19.0K | $728.0K | -$686.0K | -$205.0K | -$29.9M | -$143.0K | -$122.0K | -$53.0K | -$159.0K | -$99.0K | -$19.0K | -$244.0K | -$17.4M | -$97.0K | -$72.0K | $15.0K | -$84.0K | -$75.0K | -$54.0K | -$142.0K | $320.0K | -$184.0K | -$128.0K | -$176.0K | ||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$6.3M | -$9.8M | -$4.0M | -$5.3M | -$9.2M | -$62.3M | $6.0M | -$3.6M | -$2.2M | -$3.2M | $1.6M | -$5.8M | -$2.4M | -$2.6M | -$8.2M | -$1.5M | -$2.2M | -$1.4M | -$1.6M | -$1.2M | -$621.0K | -$587.0K | -$1.1M | -$654.0K | -$9.3M | -$43.0K | $174.0K | ||||
| Revenue From Related Parties | $27.0K | $27.0K | $524.0K | $29.0K | $27.0K | $523.0K | $527.0K | $520.0K | $523.0K | $527.0K | $520.0K | $521.0K | $522.0K | $521.0K | $447.0K | $489.0K | $505.0K | $854.0K | $770.0K | ||||||||||||
| Operating Leases Income Statement Lease Revenue | $43.0K | $43.0K | $196.0K | $45.0K | $44.0K | $228.0K | $190.0K | $236.0K | $360.0K | $370.0K | $346.0K | $588.0K | $306.0K | $383.0K | $400.0K | $298.0K | $386.0K | $219.0K | $396.0K | ||||||||||||
| Selling General And Administrative Expense | $3.1M | $3.9M | -$896.0K | $12.3M | $3.0M | $2.8M | $2.6M | $2.1M | $2.2M | $2.0M | $2.1M | $1.7M | $1.5M | $1.4M | $1.3M | $1.7M | $1.0M | $776.0K | |||||||||||||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$50.0K | -$36.0K | -$4.0K | -$28.0K | -$5.0K | $15.0K | -$46.0K | $76.0K | $21.0K | $16.0K | $10.0K | $160.0K | -$146.0K | -$9.0K | -$5.0K | -$37.0K | $38.0K | ||||||||||||||
| Parking Revenues | $155.0K | $173.0K | $190.0K | $119.0K | $122.0K | $177.0K | $221.0K | $219.0K | $224.0K | $268.0K | $189.0K | $231.0K | $246.0K | $169.0K | $215.0K | ||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $36.0K | $5.0K | $5.0K | $37.0K | -$38.0K | -$4.0K | -$34.0K | $6.0K | -$54.0K | $80.0K | $78.0K | -$85.0K | $68.0K | $10.0K | $22.0K | ||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $84.0K | $3.0K | $21.0K | $50.0K | $58.0K | $207.0K | -$697.0K | $268.0K | $103.0K | -$48.0K | -$311.0K | ||||||||||||||||||||
| In Process Research And Development | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.3M | $1.3M | $1.3M | $1.6M | $1.6M | ||||||||||||||
| Interest Income Expense Net | -$1.0K | -$1.0K | $33.0K | -$64.0K | -$221.0K | $767.0K | $101.0K | $71.0K | $2.0K | $2.0K | $1.0K | $2.0K | |||||||||||||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$119.0K | -$99.0K | -$28.0K | $10.0K | $21.0K | -$3.0K | -$18.0K | $2.0K | -$18.0K | $15.0K | -$9.0K | -$29.0K | $19.0K | ||||||||||||||||||
| General And Administrative Expense | $2.3M | $2.8M | $58.0K | $3.2M | $2.6M | $2.5M | $1.9M | $2.6M | $2.0M | $2.3M | $2.1M | $3.1M | $3.3M | -$1.7M | |||||||||||||||||
| Income Loss From Equity Method Investments | -$1.6M | -$575.0K | $96.0K | $96.0K | $96.0K | $53.0K | $103.0K | -$10.0K | -$252.0K | ||||||||||||||||||||||
| Deferred Income Taxes And Tax Credits | $6.0K | $1.0K | -$40.0K | $8.8M | |||||||||||||||||||||||||||
| Revenues Other Related Party | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | ||||||||||||||||||||||||
| Cost Of Revenue | $38.0K | $37.0K | $85.0K | ||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$1.36 | $0.25 | -$0.16 | -$0.06 | -$0.13 | -$0.22 | -$0.25 | -$0.09 | -$5.88 | ||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$1.36 | $0.26 | -$0.15 | -$0.06 | -$0.13 | -$0.22 | -$0.25 | -$0.09 | -$5.88 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $82.2M | $100.3M | $100.5M | $122.3M | $116.8M | $111.0M | $106.7M | $52.7M | $48.8M | $48.1M | |
| Cash And Cash Equivalents At Carrying Value | $2.7M | $21.5M | $26.5M | $7.9M | $12.0M | $15.8M | $11.8M | $2.3M | $5.7M | ||
| Property Plant And Equipment Net | $2.1M | $1.7M | $1.8M | $1.8M | $44.4M | $48.7M | $50.1M | $51.2M | |||
| Prepaid Expense And Other Assets Current | $430.0K | $914.0K | $4.6M | $1.1M | $273.0K | $507.0K | $421.0K | $147.0K | |||
| Minority Interest | $4.1M | -$3.7M | -$3.3M | $14.4M | $13.7M | $13.8M | $8.9M | $9.3M | |||
| Liabilities Current | $7.5M | $2.1M | $21.0M | $17.3M | $5.7M | $1.4M | $891.0K | $363.0K | |||
| Liabilities And Stockholders Equity | $96.8M | $98.8M | $118.3M | $154.1M | $136.3M | $142.1M | $116.9M | $86.2M | |||
| Liabilities | $10.6M | $2.2M | $21.1M | $17.4M | $5.8M | $17.4M | $1.4M | $24.1M | |||
| Assets Current | $72.5M | $82.9M | $108.3M | $14.8M | $9.8M | $13.3M | $44.5M | $12.2M | |||
| Assets | $96.8M | $98.8M | $118.3M | $154.1M | $136.3M | $142.1M | $116.9M | $86.2M | |||
| Accrued Liabilities Current | $1.8M | $763.0K | $1.9M | $1.2M | $1.2M | $605.0K | $500.0K | $213.0K | |||
| Other Liabilities Noncurrent | $5.0K | $55.0K | $88.0K | $48.0K | $92.0K | $292.0K | $188.0K | $70.0K | |||
| Other Assets Noncurrent | $35.0K | $9.0K | $1.4M | $1.5M | $1.6M | $1.4M | $1.1M | $540.0K | |||
| Allowance For Doubtful Accounts Receivable Current | $245.0K | $245.0K | $197.0K | $193.0K | $218.0K | $122.0K | $82.0K | $82.0K | |||
| Accounts Payable Current | $2.6M | $333.0K | $564.0K | $1.2M | $921.0K | $795.0K | $367.0K | $115.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $21.5M | $26.5M | $12.9M | $6.2M | |||||||
| Other Liabilities Current | $66.0K | $113.0K | $1.0M | $3.5M | $252.0K | $115.0K | $27.0K | $24.0K | $35.0K | ||
| Retained Earnings Accumulated Deficit | -$201.7M | -$165.5M | -$40.8M | -$16.3M | -$5.8M | -$1.1M | |||||
| Unrealized Gain On Investments Hedge Fund | $504.0K | -$4.8M | -$2.4M | -$907.0K | |||||||
| Receivables Net Current | $213.0K | $157.0K | $235.0K | $267.0K | $450.0K | $287.0K | $264.0K | ||||
| Investments Hedge Funds | $5.3M | $7.5M | $5.1M | $4.2M | |||||||
| Gain Loss On Investments Hedge Fund | $220.0K | -$504.0K | $4.8M | $2.4M | $907.0K | ||||||
| Long Term Investments | $79.1M | $70.0M | $70.0M | $13.3M | $11.7M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $50.1M | -$18.8M | -$5.0M | $13.7M | $6.6M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $3.8M | $3.8M | $4.0M | $2.3M | |||||||
| Cash And Cash Equivalents Period Increase Decrease | $6.6M | -$5.8M | -$3.8M | $4.0M | $9.4M | -$3.3M | |||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | $3.7M | $3.7M | $3.8M | $3.8M | |||||||
| Investments Other Pharmaceuticals | $477.0K | $1.2M | $2.0M | ||||||||
| Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $111.0K | -$353.0K | -$63.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $79.2M | $85.2M | $94.4M | $80.6M | $69.4M | $73.5M | $86.3M | $86.1M | $104.9M | $98.2M | $98.5M | $100.1M | $103.4M | $98.1M | $102.9M | $98.7M | $126.8M | $120.8M | $115.6M | $122.1M | $124.1M | $125.2M | $118.0M | $118.8M | $106.4M | $105.4M | $42.9M | |||||||
| Cash And Cash Equivalents At Carrying Value | $37.8M | $45.5M | $52.8M | $37.9M | $48.3M | $8.2M | $7.4M | $7.1M | $13.2M | $15.4M | $9.7M | $22.2M | $72.4M | $4.7M | $6.1M | $7.2M | $6.2M | $8.4M | $9.5M | $10.8M | $13.0M | $14.8M | $10.1M | $10.6M | $12.0M | $11.5M | $11.7M | $11.9M | ||||||
| Property Plant And Equipment Net | $1.5M | $1.6M | $1.6M | $1.6M | $1.9M | $2.1M | $2.2M | $2.1M | $1.7M | $1.7M | $1.7M | $1.8M | $42.2M | $42.5M | $42.9M | $43.6M | $43.8M | $44.1M | $47.8M | $48.3M | $48.6M | $49.2M | $49.4M | $49.7M | $50.6M | $51.0M | ||||||||
| Prepaid Expense And Other Assets Current | $873.0K | $513.0K | $786.0K | $837.0K | $725.0K | $2.9M | $445.0K | $487.0K | $2.9M | $146.0K | $512.0K | $768.0K | $2.3M | $903.0K | $428.0K | $625.0K | $116.0K | $460.0K | $336.0K | $326.0K | $540.0K | $840.0K | $588.0K | $484.0K | $645.0K | $191.0K | ||||||||
| Minority Interest | $4.1M | $4.0M | $4.0M | $3.9M | $3.2M | $3.9M | $4.5M | -$2.7M | -$3.7M | -$3.6M | -$3.6M | -$3.4M | -$3.2M | -$3.2M | $14.3M | $14.5M | $14.6M | $13.7M | $13.8M | $13.9M | $13.8M | $8.9M | $9.0M | $8.7M | $9.5M | $9.7M | ||||||||
| Liabilities Current | $12.4M | $12.1M | $11.6M | $11.0M | $7.1M | $7.2M | $7.5M | $3.3M | $934.0K | $1.4M | $2.0M | $3.2M | $17.8M | $22.8M | $17.3M | $4.9M | $10.8M | $5.3M | $1.5M | $1.2M | $1.2M | $977.0K | $1.2M | $747.0K | $685.0K | $532.0K | ||||||||
| Liabilities And Stockholders Equity | $99.3M | $105.4M | $114.1M | $108.1M | $83.0M | $87.8M | $101.6M | $106.1M | $95.5M | $96.4M | $98.6M | $103.2M | $112.8M | $122.6M | $130.4M | $146.2M | $146.2M | $134.6M | $137.4M | $139.2M | $140.4M | $143.5M | $144.2M | $116.6M | $115.1M | $77.6M | ||||||||
| Liabilities | $16.1M | $16.2M | $15.7M | $23.6M | $10.5M | $10.5M | $11.1M | $3.9M | $990.0K | $1.5M | $2.0M | $3.3M | $17.9M | $22.9M | $17.3M | $5.0M | $10.9M | $5.3M | $1.6M | $1.3M | $1.4M | $16.6M | $16.3M | $1.5M | $134.0K | $25.0M | ||||||||
| Assets Current | $42.4M | $48.3M | $56.7M | $42.4M | $65.8M | $70.5M | $73.8M | $75.1M | $77.5M | $85.0M | $90.0M | $94.9M | $62.5M | $71.5M | $78.5M | $6.0M | $6.7M | $8.2M | $9.2M | $10.3M | $11.7M | $14.6M | $15.7M | $34.4M | $44.2M | $12.4M | ||||||||
| Assets | $99.3M | $105.4M | $114.1M | $108.1M | $83.0M | $87.8M | $101.6M | $106.1M | $95.5M | $96.4M | $98.6M | $103.2M | $112.8M | $122.6M | $130.4M | $146.2M | $146.2M | $134.6M | $137.4M | $139.2M | $140.4M | $143.5M | $144.2M | $116.6M | $115.1M | $77.6M | ||||||||
| Accrued Liabilities Current | $2.8M | $3.9M | $3.3M | $1.9M | $1.4M | $1.4M | $1.7M | $845.0K | $325.0K | $592.0K | $1.3M | $1.6M | $1.3M | $6.6M | $1.3M | $861.0K | $643.0K | $443.0K | $728.0K | $579.0K | $564.0K | $203.0K | $650.0K | $431.0K | $296.0K | $423.0K | ||||||||
| Other Liabilities Noncurrent | $27.0K | $27.0K | $27.0K | $25.0K | $13.0K | $87.0K | $56.0K | $52.0K | $49.0K | $44.0K | $85.0K | $84.0K | $81.0K | $33.0K | $33.0K | $33.0K | $92.0K | $92.0K | $210.0K | $210.0K | $195.0K | $174.0K | $70.0K | $95.0K | ||||||||||
| Other Assets Noncurrent | $28.0K | $29.0K | $34.0K | $41.0K | $20.0K | $27.0K | $73.0K | $42.0K | $42.0K | $9.0K | $9.0K | $11.0K | $1.4M | $1.4M | $1.5M | $1.5M | $1.5M | $1.6M | $1.5M | $1.5M | $1.2M | $1.2M | $1.1M | $920.0K | $787.0K | |||||||||
| Allowance For Doubtful Accounts Receivable Current | $245.0K | $245.0K | $245.0K | $245.0K | $245.0K | $245.0K | $245.0K | $245.0K | $180.0K | $180.0K | $242.0K | $186.0K | $230.0K | $212.0K | $183.0K | $117.0K | $256.0K | $143.0K | $170.0K | $170.0K | $86.0K | $91.0K | $82.0K | $82.0K | $82.0K | |||||||||
| Accounts Payable Current | $8.2M | $6.8M | $6.9M | $7.8M | $2.5M | $2.7M | $2.6M | $509.0K | $616.0K | $443.0K | $1.4M | $873.0K | $1.1M | $1.1M | $753.0K | $495.0K | $1.2M | $700.0K | $569.0K | $621.0K | $755.0K | $535.0K | $298.0K | $362.0K | $89.0K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $37.8M | $45.5M | $52.8M | $37.9M | $48.3M | $8.2M | $2.7M | $7.4M | $7.1M | $13.2M | $15.4M | $9.7M | $22.8M | $29.0M | $70.0M | $77.4M | $4.7M | $6.1M | ||||||||||||||||
| Other Liabilities Current | $93.0K | $107.0K | $112.0K | $168.0K | $140.0K | $115.0K | $174.0K | $197.0K | $166.0K | $611.0K | $246.0K | $121.0K | $235.0K | $162.0K | $141.0K | $57.0K | $48.0K | $15.0K | $19.0K | $20.0K | $18.0K | $27.0K | $20.0K | |||||||||||
| Retained Earnings Accumulated Deficit | -$248.5M | -$242.1M | -$232.3M | -$220.2M | -$215.4M | -$210.7M | -$197.3M | -$164.9M | -$171.0M | -$167.3M | -$168.6M | -$167.1M | -$163.9M | -$160.7M | -$155.1M | -$170.1M | -$28.4M | -$25.9M | -$17.7M | -$10.9M | -$8.7M | -$7.4M | -$3.7M | -$2.6M | -$1.6M | -$192.0K | ||||||||
| Unrealized Gain On Investments Hedge Fund | $131.0K | -$378.0K | $127.0K | $341.0K | $454.0K | -$211.0K | -$738.0K | -$2.5M | -$944.0K | $28.0K | -$557.0K | $37.0K | -$466.0K | $148.0K | ||||||||||||||||||||
| Receivables Net Current | $249.0K | $272.0K | $135.0K | $631.0K | $616.0K | $712.0K | $248.0K | $124.0K | $309.0K | $261.0K | $325.0K | $229.0K | $672.0K | $356.0K | $379.0K | $406.0K | $226.0K | |||||||||||||||||
| Investments Hedge Funds | $4.9M | $5.0M | $4.6M | $4.8M | $4.7M | $5.0M | $5.5M | $9.7M | $8.9M | $6.5M | $5.6M | $5.6M | $5.1M | $4.6M | $4.2M | $4.3M | ||||||||||||||||||
| Gain Loss On Investments Hedge Fund | $51.0K | -$166.0K | $378.0K | -$127.0K | $211.0K | $944.0K | -$37.0K | |||||||||||||||||||||||||||
| Long Term Investments | $750.0K | $500.0K | $79.1M | $79.1M | $70.0M | $70.0M | $70.0M | $70.0M | $70.0M | $70.0M | $23.3M | $11.7M | $11.7M | |||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.2M | $5.5M | -$8.3M | -$3.7M | $64.5M | |||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $3.9M | $3.8M | $3.8M | $3.8M | $3.8M | $3.7M | $3.8M | $3.8M | $3.8M | $4.1M | $4.1M | $4.2M | $2.0M | $2.4M | ||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $64.5M | $1.0M | -$1.3M | -$5.7M | -$237.0K | |||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | $3.9M | $3.8M | $3.8M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.8M | $3.8M | |||||||||||||||||||||
| Investments Other Pharmaceuticals | $126.0K | $254.0K | $321.0K | $477.0K | $477.0K | $477.0K | $477.0K | $477.0K | $477.0K | $477.0K | $1.7M | $2.0M | $2.0M | |||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $358.0K | $358.0K | $358.0K | $219.0K | $135.0K | $132.0K | -$38.0K | -$88.0K | -$146.0K | -$389.0K | $308.0K | $40.0K | -$48.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $2.1M | $2.3M | $2.2M | -$917.0K | $6.6M | $684.0K | $51.0K | |||
| Financing Cash Flow * | $24.8M | -$179.0K | -$15.2M | $103.9M | $30.3M | -$96.0K | $30.9M | $1.8M | $22.3M | $265.0K |
| Investing Cash Flow * | $44.0M | -$10.8M | $21.2M | -$63.8M | -$8.2M | -$1.0M | -$31.2M | $4.1M | -$11.2M | -$3.7M |
| Operating Cash Flow * | -$18.9M | -$7.8M | -$10.9M | -$26.1M | -$15.6M | -$4.7M | -$3.1M | -$1.8M | -$1.6M | $72.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$818.0K | -$673.0K | -$373.0K | $3.5M | $802.0K | -$234.0K | $86.0K | $258.0K | $130.0K | -$323.0K |
| Stock Issued During Period Value Share Based Compensation | $2.1M | $2.3M | $3.1M | $18.1M | $6.6M | $476.0K | $265.0K | $51.0K | ||
| Increase Decrease In Other Operating Assets | -$22.0K | $27.0K | -$130.0K | -$63.0K | $168.0K | -$275.0K | $586.0K | $481.0K | -$30.0K | |
| Increase Decrease In Other Current Liabilities | -$67.0K | -$938.0K | $781.0K | $3.6M | $137.0K | $88.0K | $3.0K | -$10.0K | $11.0K | $17.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$146.0K | -$827.0K | $52.0K | $164.0K | $713.0K | $533.0K | -$35.0K | $50.0K | $9.0K | |
| Payments To Acquire Property Plant And Equipment | $4.0K | $143.0K | $2.0K | $206.0K | $534.0K | $399.0K | $710.0K | $1.8M | $1.6M | |
| Depreciation Depletion And Amortization | $78.0K | $72.0K | $70.0K | $1.9M | $1.8M | $1.7M | $1.7M | $1.6M | ||
| Increase Decrease In Accounts Receivable | $151.0K | $150.0K | $161.0K | -$87.0K | $285.0K | $23.0K | $7.0K | $109.0K | ||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $122.0K | -$22.0K | -$298.0K | $3.0K | $3.0K | |||||
| Increase Decrease In Due To Related Parties | -$67.0K | $136.0K | -$65.0K | $654.0K | $2.0K | -$2.6M | -$3.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $598.0K | $359.0K | $649.0K | $1.2M | $1.0M | -$10.9M | $7.9M | $304.0K | $505.0K | $214.0K | $135.0K | $109.0K | $94.0K | ||||||||||||
| Financing Cash Flow * | -$30.0K | -$48.0K | $807.0K | -$15.0M | $97.9M | $43.0K | $118.0K | ||||||||||||||||||
| Investing Cash Flow * | -$430.0K | $8.6M | -$6.8M | $14.0M | -$26.9M | $3.6M | -$321.0K | -$5.2M | -$223.0K | ||||||||||||||||
| Operating Cash Flow * | -$6.8M | -$3.0M | -$2.1M | -$2.6M | -$6.5M | -$2.7M | -$936.0K | -$724.0K | -$29.0K | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$273.0K | -$35.0K | -$796.0K | -$566.0K | -$649.0K | $187.0K | -$217.0K | $63.0K | -$6.0K | ||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $387.0K | $598.0K | $353.0K | $502.0K | $359.0K | $496.0K | $715.0K | $649.0K | $591.0K | $780.0K | $1.2M | $1.0M | $8.0M | $7.9M | $304.0K | $214.0K | $135.0K | $109.0K | $94.0K | $91.0K | $35.0K | $30.0K | $10.0K | ||
| Increase Decrease In Other Operating Assets | -$8.0K | $33.0K | $28.0K | -$54.0K | -$30.0K | $289.0K | $13.0K | $140.0K | |||||||||||||||||
| Increase Decrease In Other Current Liabilities | -$3.0K | -$1.0K | -$908.0K | $103.0K | -$124.0K | -$122.0K | -$12.0K | -$6.0K | -$25.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$118.0K | -$266.0K | $1.0M | $48.0K | -$490.0K | -$196.0K | -$138.0K | $79.0K | |||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $6.0K | $29.0K | $145.0K | $321.0K | $26.0K | $223.0K | |||||||||||||||||||
| Depreciation Depletion And Amortization | $17.0K | $22.0K | $19.0K | $437.0K | $466.0K | $429.0K | $425.0K | ||||||||||||||||||
| Increase Decrease In Accounts Receivable | -$214.0K | -$225.0K | $496.0K | $80.0K | -$173.0K | $92.0K | $88.0K | ||||||||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $2.0K | -$3.0K | $4.0K | $48.0K | $15.0K | ||||||||||||||||||||
| Increase Decrease In Due To Related Parties | -$84.0K | $26.0K | -$37.0K | $171.0K | -$260.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.04 | -$1.45 | -$0.08 | -$6.31 | -$1.49 | -$0.66 | -$0.35 | -$0.93 | $0.01 | $0.06 |
| Earnings Per Share Basic | $-1.04 | $-1.45 | $-0.08 | $-6.31 | $-1.49 | $-0.93 | $0.01 | $0.06 | ||
| Weighted Average Number Of Shares Outstanding Basic | 29.4M | 23.7M | 23.3M | 19.8M | 16.5M | 12.5K | 12.5K | 12.5K | ||
| Weighted Average Number Of Diluted Shares Outstanding | 29.4M | 23.7M | 23.3M | 19.8M | 16.5M | 12.5K | 12.5K | 12.5K | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 16.5M | 15.8M | 13.3M | 12.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.13 | -$0.19 | -$0.19 | -$0.19 | -$0.37 | -$1.36 | $0.25 | -$0.15 | -$0.06 | -$0.14 | $0.07 | -$0.28 | -$0.12 | -$5.91 | -$0.15 | -$0.50 | -$0.09 | -$0.14 | -$0.08 | -$0.10 | -$0.07 | -$0.08 | -$0.75 | -$0.05 | -$0.06 | -$0.07 | $0.01 | -$0.01 | -$0.01 | $0.01 |
| Earnings Per Share Basic | $-0.13 | $-0.19 | $-0.19 | $-0.19 | $-0.37 | $-1.36 | $0.26 | $-0.15 | $-0.06 | $-0.14 | $0.07 | $-0.28 | $-0.12 | $-0.15 | $-0.75 | $-0.05 | $-0.06 | $-0.07 | $0.01 | $-0.01 | $-0.01 | $0.01 | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 51.2M | 51.2M | 25.2M | 24.2M | 24.1M | 23.8M | 23.6M | 23.6M | 23.4M | 23.2M | 23.0M | 19.8M | 19.7M | 18.9M | 16.7M | 12.5M | 12.5M | |||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 51.2M | 51.2M | 25.2M | 24.2M | 24.1M | 23.8M | 24.4M | 23.6M | 23.4M | 23.2M | 23.0M | 19.8M | 19.7M | 18.9M | 12.5M | 12.5M | ||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 19.7M | 19.9M | 16.7M | 16.2M | 15.8M | 15.8M | 15.8M | 15.6M | 13.9M | 13.5M | 12.6M | 12.5M | 12.5M | 12.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $288.0K | $225.0K | $78.0K | $72.0K | $70.0K | $1.9M | $1.8M | $1.7M | $1.7M | $1.6M |
| Foreign Currency Transaction Gain Loss Before Tax | -$53.0K | -$42.0K | -$5.0K | $10.0K | -$5.0K | $47.0K | $32.0K | $86.0K | -$13.0K | |
| Interest Income Other | $2.0M | $2.4M | $3.3M | $201.0K | $2.0K | $37.0K | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $136.0K | $218.0K | $75.0K | $185.0K | ||||||
| Provision For Doubtful Accounts | $20.0K | -$1.2M | $4.0K | $193.0K | $96.0K | $122.0K | $82.0K | |||
| Additional Paid In Capital | $159.1M | $129.1M | $112.9M | $103.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $55.0K | $50.0K | $62.0K | $90.0K | $86.0K | $102.0K | $38.0K | $17.0K | $19.0K | $19.0K | $22.0K | $17.0K | $18.0K | $19.0K | $201.0K | $441.0K | $437.0K | $474.0K | $473.0K | $466.0K | $436.0K | $431.0K | $429.0K | $422.0K | $429.0K | $425.0K | $411.0K | $434.0K | |
| Foreign Currency Transaction Gain Loss Before Tax | -$15.0K | $46.0K | -$76.0K | -$21.0K | -$16.0K | -$10.0K | -$160.0K | $146.0K | $9.0K | $5.0K | -$1.0K | -$5.0K | $19.0K | -$28.0K | $107.0K | $11.0K | $136.0K | $51.0K | |||||||||||
| Interest Income Other | $337.0K | $399.0K | $472.0K | $489.0K | $568.0K | $502.0K | $693.0K | $582.0K | $1.5M | $562.0K | $208.0K | $53.0K | $188.0K | $2.0K | |||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $33.0K | $27.0K | $48.0K | $30.0K | $43.0K | $39.0K | $26.0K | $151.0K | $6.0K | $1.0K | $41.0K | $30.0K | $39.0K | $146.0K | |||||||||||||||
| Provision For Doubtful Accounts | $2.0K | $19.0K | $38.0K | $48.0K | |||||||||||||||||||||||||
| Additional Paid In Capital | $263.5M | $262.9M | $263.2M | $262.0M | $254.9M | $253.9M | $264.9M | $151.3M | $142.7M | $129.4M | $129.0M | $128.8M | $128.6M | $117.4M | $117.3M | $103.8M | $103.5M |
Most recent annual filing with the SEC: October 29, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.